Ketoprofen Sf (Ketoprofen)

Ketoprofen works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, it reduces inflammation, pain signalling, fever, and the swelling associated with tissue injury.

The dose of Ketoprofen Sf is determined by the prescribing healthcare professional based on the patient’s clinical condition, severity of pain or inflammation, weight, renal and hepatic function, and any concomitant medications. No fixed regimen is provided here; the prescriber sets the appropriate dose.

Safety data for ketoprofen during pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should be avoided unless the potential benefit justifies the potential risk to the fetus or infant, and only under medical supervision.

To order Ketoprofen Sf, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Ketoprofen is a non‑selective NSAID like ibuprofen but generally has a higher potency for COX inhibition, which can provide stronger analgesic and anti‑inflammatory effects at comparable doses. However, its risk profile for gastrointestinal and renal adverse events may also be higher, so clinicians weigh efficacy against safety for each patient.

Ketoprofen Sf should be stored at ambient temperature, below 25 °C. Keep the vials in their original packaging, protect them from moisture and direct light, and avoid freezing. Follow any additional handling instructions provided on the label.

Ketoprofen Sf is administered by a qualified healthcare professional as a single intramuscular injection. The injection site is typically the gluteal muscle, and the volume and concentration are determined by the prescriber. It should be given under aseptic conditions.

The most serious risks include gastrointestinal ulceration or bleeding, acute renal impairment, and severe hypersensitivity reactions such as anaphylaxis, Stevens‑Johnson syndrome, or toxic epidermal necrolysis. Patients should be monitored for signs of these events, especially if they have pre‑existing risk factors.

Ketoprofen Sf should not be used by patients with known hypersensitivity to ketoprofen or other NSAIDs, active gastrointestinal ulcer or bleeding, severe renal or hepatic impairment, and those receiving anticoagulant therapy where bleeding risk is unacceptable. Caution is also advised in the elderly and in patients with cardiovascular disease.